Qi MH, Zhou B, Su ML, Pan JY, Zhang H
[Escitalopram for Intervention of Psychiatric Adverse Events During Peginterferon-alfa-2a and Ribavirin Treatment for Chronic Hepatitis C].
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University. 2013 Jul 20; 33: 1012-6.
To evaluate the risk factors of psychiatric adverse events associated with PEG interferon and ribavirin treatment for chronic hepatitis C and assess the efficacy of escitalopram intervention for these adverse effects.